ESTRO 2024 - Abstract Book

S1321

Clinical - Head & neck

ESTRO 2024

Patients who returned PROMs were grouped according to age (<50, 50-70, >70). The median number of SCs reported by these patients was 0- 1 for all age groups. ‘Dry mouth’ was identified as the top concern in all groups with ‘fear of recurrence’ identified as the top psychological concern. 28 questionnaires were returned by patients transferred to PFU at the end of the second post-treatment year (median SC’s identified per patient = 1), 38 by patients in the third year (median SCs identified per patient = 0) and 30 by patients in the fourth post- treatment year (median SC’s identified per patient = 1).

Conclusion:

Patients within PFU identify few SCs, indicating a good QOL. This would suggest that patients who are discharged from routine oncology follow-up onto the PFU pathway, do not suffer significantly from treatment or disease related morbidity. Treatment modality, age or post-treatment year, appeared to have little overall effect on QOL. Patients with an oral cavity cancer diagnosis identify three times the number of SCs compared to other tumour subsites. This would indicate the necessity for increased support for these patients after treatment. To draw meaningful conclusions regarding the QOL impact of disease and treatment for oral cavity cancer, further longitudinal data collection is required. The majority of concerns raised were associated with physical health, particularly ‘dry mouth.’ Patients identify ‘fear of recurrence’ as impacting QOL, despite being reassured that their chance of disease recurrence is low. Close links with late effects resources need to be established to support patients with the ongoing impact of disease and treatment, particularly with self- managing ‘dry mouth’ and the ongoing impact of fear of disease recurrence. A qualitative research study (EMPOWER - IRAS 320336) is underway to further establish the QOL of these patients and explore how the PFU protocol needs to be modified to provided more individualised care.

Keywords: PROMs, Head and Neck, Personalised Follow-Up

References:

1. NHSE (2019) The NHS Long Term Plan. Available at: https://www.longtermplan.nhs.uk

1663

Digital Poster

Late Diffusion Weighted Imaging (DWI) salivary gland changes related to dose and xerostomia scores

Yan Li 1 , Chris W.J. van der Weijden 2,3 , Roel J.H.M. Steenbakkers 1 , Johannes A. Langendijk 1 , Anouk van der Hoorn 2 , Nanna M. Sijtsema 1 , Lisanne V. van Dijk 1